Mood Disorders

Latest News

Endocannabinoid System
SYT-510: First-in-Class Inhibitor Targets Endocannabinoid System to Improve Mental Health Outcomes

September 24th 2025

Synendos Therapeutics reveals promising phase 1 results for SYT-510, a novel ECS modulator targeting anxiety and CNS disorders with potential for improved patient outcomes.

mania
An Update on Hyperthymic Temperament

September 18th 2025

kids AI chatbots dangers artificial intelligence
Chatbots Can Be Dangerous For Kids

September 16th 2025

cannabidiol CBD crystal
New Preclinical Data on ART12.11 for the Treatment of Mood and Anxiety Disorders

September 10th 2025

genetics environment inflammation concussion mental illness
Contribution of Genetics, Environment, and Inflammation to Development of Severe Mental Illness

September 3rd 2025

Video Interviews
Podcasts
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.